Expert Opinion on Orphan Drugs (ISSN 2167-8707) is a journal published by Taylor & Francis in the United Kingdom. It covers Medicine, Pharmacology, Toxicology and Pharmaceutics and Pharmacology & Toxicology and Pharmaceutics (miscellaneous). It is indexed in PubMed and HEC. Recorded metrics: HEC Y-Category. Article processing charge: USD 2,950. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, SJR and SCImago rank, indexing, open access status, APC, aims and scope, about the journal, journal website and registration details from the most reputable indexes, in one place.
Expert Opinion on Orphan Drugs
Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.
Journal lists: HEC Y category journals · PubMed journals · SCImago journals
Quick answers about Expert Opinion on Orphan Drugs
Is Expert Opinion on Orphan Drugs HEC recognised?
Yes. The catalogue records Expert Opinion on Orphan Drugs in HEC category Y of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.
Is Expert Opinion on Orphan Drugs indexed in Scopus?
Expert Opinion on Orphan Drugs is not listed as Scopus-indexed in this record. Check the Scopus Sources page for its current status.
Is Expert Opinion on Orphan Drugs in Web of Science?
Expert Opinion on Orphan Drugs is not listed as a Web of Science journal in this record. Confirm on Clarivate's Master Journal List.
What is the impact factor of Expert Opinion on Orphan Drugs?
No impact factor is recorded. OpenAlex reports a 2-year mean citedness of 7.38, a similar citation measure based on its own data.
Is Expert Opinion on Orphan Drugs open access, and what does it charge?
Expert Opinion on Orphan Drugs is not recorded as fully open access and its APC is USD 2,950. Fees change, so check the journal's website before you submit.
Who publishes Expert Opinion on Orphan Drugs?
Expert Opinion on Orphan Drugs is published by Taylor & Francis in United Kingdom, under ISSN 2167-8707.
Research profile
- 850articles indexed
- 6,063citations
- 35h-index
- 7.382-year mean citedness
- 2012first year indexed
Main research topics: Lysosomal Storage Disorders Research, Metabolism and Genetic Disorders, Pharmaceutical Economics and Policy, Glycogen Storage Diseases and Myoclonus, Chronic Lymphocytic Leukemia Research, Genomics and Rare Diseases.
Source: OpenAlex (CC0), retrieved 21 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.